{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6013",
      "entity_text" : "testosterone",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0087" ]
    }
  },
  "verbose_text" : "XREF_BIBR In men with CRPC treated with enzalutamide, levels of plasma testosterone, bone marrow testosterone and plasma DHT do not decrease, whereas nuclear AR expression is reduced or unchanged.",
  "reading_complete" : "2020-08-05T22:19:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:17:19Z",
  "trigger" : "levels",
  "evidence" : [ "levels of plasma testosterone" ],
  "pmc_id" : "3622394",
  "score" : 0
}